Dishman Carbogen Amcis Share Price
174.61-2.38 (-1.34%)
-34.74% past 1 Year
News
Dishman Carbogen Q4 EBITDA rises YoY but margin contracts on lower profitability
Equity
DCAL
Dishman Carbogen Q4 revenue grows strongly year-on-year to Rs 851 crores
Equity
DCAL
Dishman Carbogen reports lower quarterly net profit in latest result
Equity
DCAL
Dishman Carbogen Amcis Subsidiary Carbogen Amcis B.V. Secures GMP Compliance Certificate for Veenendaal Facility.
Equity
DCAL
Dishman Carbogen Amcis Q3 FY26 EBITDA Decline: YoY Margin Contraction
Equity
DCAL
Dishman Carbogen Amcis Reports Q3 Net Loss of Rs 13 Crores vs YoY Profit.
Equity
DCAL
Dishman Carbogen Amcis board clears Rs 50 crores secured NCD issue at 10 percent
Equity
DCAL
Dishman Carbogen Amcis Board Meeting on Dec 27 to Discuss NCD Funding Proposal.
Equity
DCAL
Dishman Carbogen Amcis subsidiary secures expanded Swiss credit capacity through refinancing initiative.
Equity
DCAL
Dishman Carbogen Amcis Q2 FY26: Net profit rises sharply as revenue falls; operating margin expands
Equity
DCAL
Dishman Carbogen Amcis merges Carbogen Amcis Specialities AG and Carbogen Amcis Innovations AG
Equity
DCAL
Dishman Carbogen Amcis announces partnership with Celonic Group for ADC platform development
Equity
DCAL
Dishman Carbogen Amcis rises on receiving EIR from USFDA
Equity
DCAL
Dishman Carbogen Amcis receives EIR from USFDA
Equity
DCAL
Dishman Carbogen Amcis: Company Gets Eir From Us Fda Confirming Inspection Closure. ??
Equity
DCAL
Dishman Carbogen Amcis: Co Is Expanding Complex Api Capabilities, Deepening Cdmo Partnerships, And Leveraging Regulatory Clearances In The U.S. & Eu To Tap High-Value Pharma Outsourcing Demand
Equity
DCAL
Dishman Carbogen Amcis: Q1 Ebitda 140.00 Crores Rupees Vs 30.00 Crores (Yoy) || Q1 Ebitda Margin 19.82% Vs 5.73% (Yoy)
Equity
DCAL
Dishman Carbogen Amcis: Q1 Cons Net Profit 23.40 Crores Rupees Vs Loss 77.60 Crores (Yoy) || Q1 Revenue 708.00 Crores Rupees Vs 523.00 Crores (Yoy)
Equity
DCAL
Dishman Carbogen Amc - Quaterly Results
Equity
DCAL
Dishman Carbogen Amc - Quaterly Results
Equity
DCAL